Accelerate Development with Lannett CDMO
- Streamlined development of oral solid dose formulations
- Extensive expertise and high-volume manufacturing
- Commitment to quality and regulatory compliance
Our track record speaks volumes
- 17 approved product applications since 2019
- 96% average product yield rate
- Zero critical FDA Form 483 observations
Learn More About Partnering with Lannett.
https://www.lannettcdmo.com/
Aimer
Commentaire
Partagez
